Education
About Us
Working with TipRanks
Follow Us
Veracyte (VCYT)
NASDAQ:VCYT
Earnings Data
Report Date
Nov 11, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.32Last Year’s EPS
0.19Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reveals a positive outlook for Veracyte, with strong revenue growth driven by Decipher and Afirma tests, successful launch of new products, and an impressive cash position. However, there are challenges such as a decline in product revenue and the impact of the Veracyte SAS sale on future margins.Company Guidance
Strong Revenue Growth
Veracyte delivered 14% revenue growth year-over-year with total revenue of $130 million. Testing revenue grew 14% year-over-year, or 16% when adjusted for Envisia.
Decipher Volume Growth
Decipher tests delivered approximately 25,500 tests, resulting in a year-over-year volume growth of 28%, marking the 13th consecutive quarter of over 25% year-over-year volume growth.
Adjusted EBITDA Margin Exceeds Expectations
Veracyte achieved an adjusted EBITDA margin of 27.5%, vastly exceeding expectations.
Successful Launch of Decipher Prostate Test
The Decipher Prostate test was launched for use in the metastatic population, with positive feedback from physicians and potential guideline inclusion in the coming years.
Afirma Volume Growth
Afirma’s volume growth increased 8% year-over-year, with approximately 16,950 tests conducted.
Cash Position
The company ended the quarter with $320.7 million in cash and cash equivalents.
VCYT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
VCYT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 06, 2025 | $23.97 | $27.68 | +15.48% |
May 07, 2025 | $30.84 | $31.21 | +1.20% |
Feb 24, 2025 | $39.36 | $33.46 | -14.99% |
Nov 06, 2024 | $36.59 | $37.34 | +2.05% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Veracyte (VCYT) report earnings?
Veracyte (VCYT) is schdueled to report earning on Nov 11, 2025, After Close (Confirmed).
What is Veracyte (VCYT) earnings time?
Veracyte (VCYT) earnings time is at Nov 11, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is VCYT EPS forecast?
VCYT EPS forecast for the fiscal quarter 2025 (Q3) is 0.32.